Stockreport

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]

Lexaria Bioscience Corp.  (LEXX) 
PDF global innovator in drug delivery platforms, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules o [Read more]